Drug maker Ranbaxy Laboratories Ltd said on Friday it was planning to achieve $3 billion in consolidated turnover by 2012 as part of its medium-term business plan.
Ranbaxy, majority owned by Japan's Daiichi Sankyo, did not give details in the notice to the Bombay Stock Exchange.